PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Banner Health
- Study ID
- NCT07178808
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Gastric Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy — PROCEDURECRS/HIPEC involves aggressive surgical cytoreduction of all visible and palpable tumors, followed by the synergistic use of heated and high dose chemotherapy to address microscopic residual disease.
Study Details
This is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology apparent peritoneal-surface only metastatic disease.
Key Dates
- Start date
- Apr 16, 2021
- Status verified
- Sep 2025
- Primary completion
- Feb 22, 2031
- Completion
- Feb 22, 2031
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapyPatients will undergo cytoreduction \& hyperthermic intraperitoneal chemotherapy
Primary Outcome Measure
To assess improvements in survival in gastric adenocarcinoma patients with occult or apparent carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [ Time Frame: From enrollment up to 60 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | Rajesh Ramanathan (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Gilbert, AZ
By research site
Related Studies
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama
- Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ CancerPHASE2 · Recruiting · University of Arizona · Tucson, Arizona
- A Study of KK2269 in Adult Participants With Solid TumorsPHASE1 · Recruiting · Kyowa Kirin Co., Ltd. · Scottsdale, Arizona
- Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid TumorsPHASE1 · Recruiting · SystImmune Inc. · Phoenix, Arizona